University of Massachusetts Medical School (UMass Medical …

Top story: FDA approves first drug to use RNA interference, based on discoveries made at UMass Medical School

The new drug, patisiran, approved Aug. 10 by the FDA, is based on the discovery of RNAi made by Craig Mello, PhD, and Andrew Fire, PhD. It was developed by Alnylam, an RNAi-based drug development company co-founded by Phillip Zamore, PhD.

Continue reading here:

University of Massachusetts Medical School (UMass Medical …

Related Post

Comments are closed.